Dr. Andrew L. Pecora

Dr. Andrew L. Pecora, MD, FACP, CPE, is a visionary hematologist-oncologist and healthcare innovator specializing in hematologic malignancies and cellular therapies. He is the Founder and Executive Chairman of COTA, Inc., and formerly served as Chief Innovation Officer at Hackensack Meridian Health. Dr. Pecora earned his medical degree from the University of Medicine and Dentistry of New Jersey, completed his residency at The New York Hospital-Cornell Medical Center, and fellowship in Hematology and Oncology at Memorial Sloan Kettering Cancer Center. He is board-certified in Internal Medicine, Hematology, and Oncology and is widely known for his leadership in healthcare analytics and real-world evidence in oncology.

A pioneer in integrating data science into cancer care, Dr. Pecora developed innovative models that use real-world evidence to optimize patient outcomes and support value-based care initiatives. He has led numerous clinical trials in bone marrow transplantation and immune therapies and has authored over 150 peer-reviewed publications. His work has been instrumental in shaping the use of big data in precision oncology.

In addition to his clinical and research leadership, Dr. Pecora is an influential educator and healthcare strategist. He has served on advisory boards for ASCO, the National Marrow Donor Program, and various industry think tanks. Through his commitment to clinical innovation, data-driven care transformation, and mentorship, Dr. Andrew L. Pecora continues to drive the evolution of cancer care delivery.